vs

Side-by-side financial comparison of Assertio Holdings, Inc. (ASRT) and i-80 Gold Corp. (IAUX). Click either name above to swap in a different company.

i-80 Gold Corp. is the larger business by last-quarter revenue ($21.3M vs $13.5M, roughly 1.6× Assertio Holdings, Inc.).

Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As o...

i-80 Gold Corp is a mineral exploration and development firm focused on gold and silver asset operations in Nevada, US. It advances high-potential mining projects, using responsible extraction practices to deliver precious metals to global industrial and investment markets.

ASRT vs IAUX — Head-to-Head

Bigger by revenue
IAUX
IAUX
1.6× larger
IAUX
$21.3M
$13.5M
ASRT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASRT
ASRT
IAUX
IAUX
Revenue
$13.5M
$21.3M
Net Profit
$-85.6M
Gross Margin
22.0%
Operating Margin
-86.7%
-291.6%
Net Margin
-401.9%
Revenue YoY
-57.9%
Net Profit YoY
EPS (diluted)
$-4.54
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASRT
ASRT
IAUX
IAUX
Q4 25
$13.5M
$21.3M
Q3 25
$49.5M
$32.0M
Q2 25
$29.2M
$27.8M
Q1 25
$26.5M
$14.0M
Q4 24
$32.2M
Q3 24
$29.2M
$11.5M
Q2 24
$31.1M
$7.2M
Q1 24
$32.4M
Net Profit
ASRT
ASRT
IAUX
IAUX
Q4 25
$-85.6M
Q3 25
$11.4M
$-41.9M
Q2 25
$-16.4M
$-30.2M
Q1 25
$-13.5M
$-41.2M
Q4 24
Q3 24
$-2.9M
$-43.1M
Q2 24
$-3.7M
$-41.0M
Q1 24
$-4.5M
Gross Margin
ASRT
ASRT
IAUX
IAUX
Q4 25
22.0%
Q3 25
9.7%
Q2 25
2.9%
Q1 25
20.7%
Q4 24
Q3 24
-42.7%
Q2 24
-171.4%
Q1 24
Operating Margin
ASRT
ASRT
IAUX
IAUX
Q4 25
-86.7%
-291.6%
Q3 25
23.2%
-86.7%
Q2 25
-27.5%
-67.4%
Q1 25
-50.0%
-112.3%
Q4 24
-41.9%
Q3 24
-10.4%
-210.0%
Q2 24
-11.6%
-435.2%
Q1 24
-13.4%
Net Margin
ASRT
ASRT
IAUX
IAUX
Q4 25
-401.9%
Q3 25
23.1%
-130.8%
Q2 25
-56.0%
-108.5%
Q1 25
-51.1%
-293.3%
Q4 24
Q3 24
-10.0%
-374.5%
Q2 24
-11.8%
-570.8%
Q1 24
-13.9%
EPS (diluted)
ASRT
ASRT
IAUX
IAUX
Q4 25
$-4.54
$-0.10
Q3 25
$0.11
$-0.05
Q2 25
$-0.17
$-0.05
Q1 25
$-0.14
$-0.10
Q4 24
$-3.28
Q3 24
$-0.03
$-0.11
Q2 24
$-0.04
$-0.11
Q1 24
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASRT
ASRT
IAUX
IAUX
Cash + ST InvestmentsLiquidity on hand
$63.4M
$63.2M
Total DebtLower is stronger
$174.7M
Stockholders' EquityBook value
$94.0M
$346.8M
Total Assets
$267.0M
$703.4M
Debt / EquityLower = less leverage
0.50×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASRT
ASRT
IAUX
IAUX
Q4 25
$63.4M
$63.2M
Q3 25
$93.4M
$102.9M
Q2 25
$98.2M
$133.7M
Q1 25
$87.3M
$13.5M
Q4 24
$100.1M
Q3 24
$88.6M
$21.8M
Q2 24
$88.4M
$47.8M
Q1 24
$80.7M
Total Debt
ASRT
ASRT
IAUX
IAUX
Q4 25
$174.7M
Q3 25
$175.9M
Q2 25
$175.8M
Q1 25
$197.5M
Q4 24
Q3 24
Q2 24
Q1 24
$38.6M
Stockholders' Equity
ASRT
ASRT
IAUX
IAUX
Q4 25
$94.0M
$346.8M
Q3 25
$105.8M
$423.0M
Q2 25
$93.3M
$463.5M
Q1 25
$108.5M
$318.0M
Q4 24
$121.1M
Q3 24
$130.5M
$346.9M
Q2 24
$132.2M
$377.2M
Q1 24
$134.5M
Total Assets
ASRT
ASRT
IAUX
IAUX
Q4 25
$267.0M
$703.4M
Q3 25
$319.8M
$756.2M
Q2 25
$273.8M
$782.9M
Q1 25
$286.4M
$659.0M
Q4 24
$284.7M
Q3 24
$276.0M
Q2 24
$279.4M
Q1 24
$282.0M
Debt / Equity
ASRT
ASRT
IAUX
IAUX
Q4 25
0.50×
Q3 25
0.42×
Q2 25
0.38×
Q1 25
0.62×
Q4 24
Q3 24
Q2 24
Q1 24
0.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASRT
ASRT
IAUX
IAUX
Operating Cash FlowLast quarter
$-30.0M
$-34.3M
Free Cash FlowOCF − Capex
$-39.2M
FCF MarginFCF / Revenue
-184.3%
Capex IntensityCapex / Revenue
23.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-93.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASRT
ASRT
IAUX
IAUX
Q4 25
$-30.0M
$-34.3M
Q3 25
$-4.8M
$-15.2M
Q2 25
$19.1M
$-11.3M
Q1 25
$-12.5M
$-22.7M
Q4 24
$11.5M
Q3 24
$-35.0K
$-23.5M
Q2 24
$7.4M
$-24.6M
Q1 24
$7.5M
Free Cash Flow
ASRT
ASRT
IAUX
IAUX
Q4 25
$-39.2M
Q3 25
$-18.5M
Q2 25
$-12.4M
Q1 25
$-23.1M
Q4 24
Q3 24
$-23.8M
Q2 24
$-25.1M
Q1 24
FCF Margin
ASRT
ASRT
IAUX
IAUX
Q4 25
-184.3%
Q3 25
-57.8%
Q2 25
-44.7%
Q1 25
-164.1%
Q4 24
Q3 24
-206.7%
Q2 24
-349.1%
Q1 24
Capex Intensity
ASRT
ASRT
IAUX
IAUX
Q4 25
23.1%
Q3 25
10.2%
Q2 25
3.9%
Q1 25
2.5%
Q4 24
Q3 24
0.0%
2.5%
Q2 24
7.3%
Q1 24
Cash Conversion
ASRT
ASRT
IAUX
IAUX
Q4 25
Q3 25
-0.42×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASRT
ASRT

Products$12.8M95%
Other$719.0K5%

IAUX
IAUX

Granite Creek Mining Company$20.3M95%
Ruby Hill Mining Company LLC$991.0K5%
Lone Tree Minning Company$3.0K0%

Related Comparisons